Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/2010
09/07/2010US7790454 Administering a translation product of a nucleic acid sequence, high mobility group proteins, HMGI gene
09/07/2010US7790453 Enriched population of blood-derived, muscle progenitor cells expressing CD34 glycoprotein and no exogenous nucleic acids; tissue engineering
09/07/2010US7790449 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor
09/07/2010US7790419 Antiviral vectors
09/07/2010US7790408 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
09/07/2010US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases
09/07/2010US7790155 Calbindin-D28K protection against glucocorticoid induced cell death
09/07/2010US7790154 DNA viral plasmid for use as gene transfer tool in genetic engineering and genic therapy; improved exogenous transcriptional expression
09/07/2010CA2608864C Recombinant mva virus, and the use thereof
09/07/2010CA2596274C Recombinant mva virus, and the use thereof
09/07/2010CA2368814C Use of glucosylceramide synthesis inhibitors in therapy
09/02/2010WO2010099301A2 Piggybac transposon variants and methods of use
09/02/2010WO2010098667A1 Means and methods for durable inhibition of pathogens
09/02/2010WO2010098166A1 Cell adhesion inhibitor and use thereof
09/02/2010US20100222438 Methods compositions and article of manufacture for modulating bone growth
09/02/2010US20100222419 Method to inhibit cell growth using oligonucleotides
09/02/2010US20100222416 Diagnostic Marker and Therapeutic Target for Cancer
09/02/2010US20100222407 Triblock copolymers for cytoplasmic delivery of gene-based drugs
09/02/2010US20100222274 Glycosylation-deficient hepatocyte growth factor
09/02/2010US20100221820 Use of triplex structure DNA in transferring nucleotide sequences
09/02/2010US20100221746 Compositions and methods for the treatment of disease
09/02/2010US20100221731 Methods for assessing MetAP2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
09/02/2010US20100221730 Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
09/02/2010US20100221729 Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
09/02/2010US20100221357 Drug delivery product and methods
09/02/2010US20100221318 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
09/02/2010US20100221288 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/02/2010US20100221287 Streptococcus pneumoniae Polynucleotides and Sequences
09/02/2010US20100221283 Circovirus sequences associated with piglet weight loss disease (pwd)
09/02/2010US20100221276 Circovirus sequences associated with piglet weight loss disease (pwd)
09/02/2010US20100221230 Elective Collection and Banking of Autologous Peripheral Blood Stem Cells
09/02/2010US20100221225 Compositions and methods for treating glycogen storage diseases
09/02/2010DE102009009672A1 Regulatorische Nukleinsäure einer humanen Proteinase 3-Variante Regulatory nucleic acid of a human proteinase 3 variant
09/02/2010DE102007008596B4 Biologisch wirksame Moleküle auf Grundlage von PNA und siRNA, Verfahren zu deren zellspezifischen Aktivierung sowie Applikationskit zur Verabreichung Biologically active molecules on the basis of PNA and siRNA, methods for their cell-specific activation and application kit for administering
09/02/2010CA2789941A1 Infertility associated defb-126 deletion polymorphism
09/01/2010EP2224010A1 Improved gene expression
09/01/2010EP2224003A2 MicroRNA molecules
09/01/2010EP2223939A1 Transgenic mice used as models for human pathologies originating from stem cells
09/01/2010EP2223935A2 Compounds and methods for treatment and diagnosis of chlamydial infection
09/01/2010EP2223933A1 Genes encoding major capsid protein l1 of human papilloma viruses
09/01/2010EP2223932A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
09/01/2010EP2222344A2 Dendritic cell vaccine compositions and uses of same
09/01/2010EP1606409B1 Nogo receptor binding protein
09/01/2010EP1549672B1 Ablated slam-dependent cell entry
09/01/2010EP1427815B1 Methods for the industrial production of vaccines
09/01/2010EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/01/2010EP1372727B1 Biodegradable carrier and method for preparation thereof
09/01/2010CN1995065B Fusion protein for suppressing PTTG expression and its coding gene and uses
09/01/2010CN1903876B Polypeptide, nucleic acid molecule coding it and use
09/01/2010CN101821317A Method for manufacturing linear polyethylenimine (pei) for transfection purpose and linear pei obtained with such method
09/01/2010CN101821284A Novel genes and proteins of brachyspira hyodysenteriac and uses thereof
09/01/2010CN101818171A Eukaryotic expression vector of human ski gene, preparation method and application thereof
09/01/2010CN101818152A Ribonucleic acid taking liver cancer related gene DLK1 as target spot and application thereof
09/01/2010CN101818150A Neurogenesis
09/01/2010CN101818133A VSIG4 (V-set and Ig domain containing 4) and IGRP (glucose-6-phosphatase catalytic subunit-related protein) dual-gene coexpression recombinant adenovirus as well as preparation method and application thereof
09/01/2010CN101818132A Construction of chimeric rabies strain rLEP333Q-L(H) and research on biological function thereof
09/01/2010CN101816799A Gene vaccine of sperm-specific cationic channel protein CatSper1 and preparation method thereof
09/01/2010CN101816798A Gene vaccine of sperm-specific protein Ropporin and preparation method thereof
09/01/2010CN101816783A Recombinant Mycobacterium smegmatis vaccine expressing HBHA-IL-12 fusion protein
09/01/2010CN101816779A Human nuclear clusterin, vector and application thereof
09/01/2010CN101255422B siRNA sequence suppressing expression of bax gene
09/01/2010CN101041078B Biology agent for improving radiosensitization of tumor cells and the use thereof
08/2010
08/31/2010US7786282 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents
08/31/2010US7786265 Modulation of body weights; dietetics; eating disorders; for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass
08/31/2010US7786260 immunogenic; treating or preventing Helicobacter infection in a mammalian host; gastroduodenal disease
08/31/2010US7786092 Selective inhibition of pro-angiogenic VEGF pathway gene expression; Tissue targeted nanoparticle compositions comprising polymer (histidine-lysine copolymer) conjugates and nucleic acid molecules; antisense strand consists of the complement of SEQ ID NO: 286; ocular disease, arthritis, inflammation
08/31/2010US7786090 Methods and compositions for treating and preventing neurologic disorders
08/31/2010US7785888 Adeno-associated viral vector for use as heterologous gene transfer agent
08/31/2010US7785887 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes
08/31/2010US7785886 Contacting ABC1-expressing cells with a composition containing test compound and measuring biological activity by determining the level of efflux of labeled substrate ; use in treating cardiovascular disease
08/31/2010US7785877 Bovine immunodeficiency virus (BIV) based vectors
08/31/2010US7785873 Antigen arrays for treatment of bone disease
08/31/2010US7785870 Cell-specific expression/replication vector
08/31/2010US7785841 Methods for the early diagnosis of ovarian cancer
08/31/2010US7785838 Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use
08/31/2010US7785831 Overexpressing an endogenous gene in a cell, comprising introducing a vector containing a transcriptional regulatory sequence into the cell, allowing the vector to integrate into the genome of the cell by non-homologous recombination
08/31/2010US7785817 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics
08/31/2010US7785813 performing an immunoassay to detect an increase in the level of a polypeptide, relative to that in a non-cancer biological sample from the same tissue; gene expression inhibition of disease-related proteins; medical prognosis
08/31/2010US7785811 Using lutetium label probes to detect tumor secreted antigens and diagnose/prognose cell proliferative disorders
08/31/2010US7785803 Antibody diagnostic kits and methods of use
08/31/2010US7785801 Identification of surface-associated antigens for tumor diagnosis and therapy
08/31/2010US7785599 Albumin fusion proteins
08/31/2010US7785595 Stabilized anti-hepatitis B (HBV) antibody formulations
08/31/2010CA2336472C Negative-sense rna virus vector for nerve cell
08/31/2010CA2262010C Hsv strain lacking functional icp27 and icp34.5 genes
08/26/2010WO2010096458A1 Compositions and methods for preventing cardiac arrhythmia
08/26/2010WO2010096112A1 System for modulating expression of hypothalmic brain-derived neurotrophic factor (bdnf)
08/26/2010WO2010095879A2 Sirna to be bound to transcripts of apoptosis-related genes, and compositions for treating cancer using same
08/26/2010WO2010095096A1 Use of vgii3 activity modulator for the modulation of adipogenesis
08/26/2010WO2010073104A3 Improving cognitive function
08/26/2010WO2010005704A3 Novel helper plasmid, defective sindbis viral vectors and methods of use thereof
08/26/2010WO2009087110A8 Secretable hiv entry inhibitory peptides for therapy of hiv infection
08/26/2010US20100216867 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
08/26/2010US20100216733 Use of inhibitors and antisense oligonucleotides of btk for treating proliferative mastocytosis
08/26/2010US20100216716 Cell-Permeable Peptide Inhibitors Of The JNK Signal Transduction Pathway
08/26/2010US20100216713 Novel compositions and methods in cancer associated with altered expression of prlr
08/26/2010US20100216710 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis
08/26/2010US20100215696 Efficiently replicable heptitis c virus mutant, a heptitis c virus mutant comprising reporter gene, a method of preparing of hcv vaccine using the same and a method of screening anti hcv composition using the same
08/26/2010US20100215690 Circovirus sequences associated with piglet weight loss disease (pwd)
08/26/2010CA2752899A1 Compositions and methods for preventing cardiac arrhythmia
1 ... 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... 870